Literature DB >> 1310555

The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system.

J K Fazakerley1, S E Parker, F Bloom, M J Buchmeier.   

Abstract

Following intracerebral inoculation of adult Balb/c Byj mice, the MHV-4 strain of mouse hepatitis virus (MHV) had an LD50 of less than 0.1 PFU, whereas its monoclonal antibody resistant variant V5A13.1 had an LD50 of 10(4.2) PFU. To determine the basis for this difference in neurovirulence we have studied the acute central nervous system (CNS) infection of these two viruses by in situ hybridization. Both viruses infected the same, specific neuroanatomical areas, predominantly neurons, and spread via the cerebrospinal fluid, along neuronal pathways and between adjacent cells. The neuronal nuclei infected and the spread of virus within the brain are described. The main difference between the parental and variant viruses was the rate at which the infection spread. MHV-4 spread rapidly, destroying large numbers of neurons and the animals died within 4 days of infection. The variant virus spread to the same areas of the brain but at a slower rate. This difference in the rate of virus spread was also apparent from the brain virus titers. The slower rate of spread of the variant virus appears to allow intervention by the immune response. Consistent with this, the variant virus spread slowly in athymic nu/nu mice, but in the absence of an intact immune response, infection and destruction of neurons eventually reached the same extent as that of the parental virus and the mice died within 6 days of infection. We conclude that the V5A13.1 variant of MHV-4 is neuroattenuated by its slower rate of spread in the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310555      PMCID: PMC7131170          DOI: 10.1016/0042-6822(92)90306-a

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Coronavirus: organization, replication and expression of genome.

Authors:  M M Lai
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

2.  Limbic encephalitis after inhalation of a murine coronavirus.

Authors:  E Lavi; P S Fishman; M K Highkin; S R Weiss
Journal:  Lab Invest       Date:  1988-01       Impact factor: 5.662

3.  Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.

Authors:  T M Gallagher; S E Parker; M J Buchmeier
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus.

Authors:  N Hirano; T Murakami; K Fujiwara; M Matsumoto
Journal:  Jpn J Exp Med       Date:  1978-02

5.  Pathogenic characteristics of neutralization-resistant variants of JHM coronavirus (MHV-4).

Authors:  J O Fleming; M D Trousdale; S A Stohlman; L P Weiner
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

6.  The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.

Authors:  H Wege; J Winter; R Meyermann
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

7.  Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM.

Authors:  F Taguchi; S G Siddell; H Wege; V ter Meulen
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Neurovirulence of murine coronavirus JHM temperature-sensitive mutants in rats.

Authors:  H Wege; M Koga; R Watanabe; K Nagashima; V ter Meulen
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

10.  Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV.

Authors:  F Taguchi; P T Massa; V ter Meulen
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

View more
  52 in total

1.  Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure.

Authors:  C L Rowe; J O Fleming; M J Nathan; J Y Sgro; A C Palmenberg; S C Baker
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections.

Authors:  P V Rao; T M Gallagher
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 4.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

5.  Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.

Authors:  Katherine C MacNamara; Ming Ming Chua; Joanna J Phillips; Susan R Weiss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

Authors:  K Saeki; N Ohtsuka; F Taguchi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis.

Authors:  M Gromeier; H H Lu; E Wimmer
Journal:  Microb Pathog       Date:  1995-04       Impact factor: 3.738

8.  The murine coronavirus nucleocapsid gene is a determinant of virulence.

Authors:  Timothy J Cowley; Simon Y Long; Susan R Weiss
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.

Authors:  S Navas; S H Seo; M M Chua; J Das Sarma; E Lavi; S T Hingley; S R Weiss
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 10.  Coronavirus spike proteins in viral entry and pathogenesis.

Authors:  T M Gallagher; M J Buchmeier
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.